VIDEOS

IPF does not wait - The Importance of Early Diagnosis

02:40

IPF does not wait - The Importance of Early Diagnosis
Evaluation FVC Data from Impulsis on Trial

02:12

Evaluation FVC Data from Impulsis on Trial
Ofev Mortality Data

02:22

Ofev Mortality Data
How does Nintedanib benefit patients in preserving lung function

03:02

How does Nintedanib benefit patients in preserving lung function
Effect On Honeycombing Efficacy

02:44

Effect On Honeycombing Efficacy
Efficacy with Concomitant Emphysema

03:16

Efficacy with Concomitant Emphysema
Expert Opinion

02:56

Expert Opinion
Acute Exacerbation

02:06

Acute Exacerbation
Survival Analysis

05:57

Survival Analysis
Mechanism of Action

03:19

Mechanism of Actions
Patient Subgroup Analysis

09:32

Patient Subgroup Analysis
Why was data of impulsis and tomorrow pooled?

02:03

Why was data of impulsis and tomorrow pooled?
Early Use of Antifibrotic

00:57

Early Use of Antifibrotic
INPULSIS-ON Prof. Richeldi & Prof. Maher video & transcript: New guideline Impact on the Diagnosis of IPF

01:06

INPULSIS-ON Prof. Richeldi & Prof. Maher video & transcript: New guideline Impact on the Diagnosis of IPF
Vincent Cottin discuss symptoms and signs of IPF

01:50

Vincent Cottin discuss symptoms and signs of IPF
Vincent Cottin discuss the impact of diagnosis on patients

01:06

Vincent Cottin discuss the impact of diagnosis on patients
Prof. Richeldi & Prof. Maher Video Transcript: Why watch & wait?

01:50

Prof. Richeldi & Prof. Maher Video Transcript: Why watch & wait?
OFEV - INPULSIS ON (Dr Maher- Dr Richaldi)

03:29

OFEV - INPULSIS ON (Dr Maher- Dr Richaldi)
Life Happens - Car Crash

00:52

Life Happens - Car Crash
Customer Journey

05:14

Customer Journey
RECIRCUIT - Video Infographic

02:04

RECIRCUIT - Video Infographic
Patient Elderly with Moderate Renal Impairment

03:10

Patient Elderly with Moderate Renal Impairment
Aortic Dissection Case

04:12

Aortic Dissection Case
Praxbind availabality

01:16

Praxbind availabality
Shower Fall

01:17

Shower Fall
Patient Infographic

02:58

Patient Infographic
Praxbind MOA

01:01

Praxbind MOA
What is the leading cause of death in patients with type 2 diabetes?

01:32

What is the leading cause of death in patients with type 2 diabetes?
What are your thoughts on the 35% relative risk reduction?

01:42

What are your thoughts on the 35% relative risk reduction?
Is the glucose-lowering effect of Jardiance a barrier to cardiologists prescribing it?

01:52

Is the glucose-lowering effect of Jardiance a barrier to cardiologists prescribing it?
What were the key findings from EMPA-REG OUTCOME?

02:29

What were the key findings from EMPA-REG OUTCOME?
Should we move beyond glucose lowering as the main treatment goal?

02:46

Should we move beyond glucose lowering as the main treatment goal?
What does lowering the risk of CV death? - John Wilding

01:56

What does lowering the risk of CV death? - John Wilding
Are patients with type 2 diabetes at elevated CV risk?

02:23

Are patients with type 2 diabetes at elevated CV risk?
Early reduction in CV death with Jardiance

01:01

Early reduction in CV death with Jardiance
Reduce the risk of mortality with Jardiance

01:01

Reduce the risk of mortality with Jardiance
Reduce the risk of hospitalization for heart failure with Jardiance

01:01

Reduce the risk of hospitalization for heart failure with Jardiance
Patients could benefit from Jardiance across baseline HbA1c

01:00

Patients could benefit from Jardiance across baseline HbA1c
Going beyond standard care of with Jardiance

01:03

Going beyond standard care of with Jardiance
Reduce the risk of CV death with Jardiance-38 Percent

01:01

Reduce the risk of CV death with Jardiance - 38%
Is Jardiance a medication for both endocrinologists and cardiologists?

02:23

Is Jardiance a medication for both endocrinologists and cardiologists?
What are your views on the 38% relative risk reduction in CV death with Jardiance?

02:22

What are your views on the 38% relative risk reduction in CV death with Jardiance?
What does lowering the risk of CV death? - Lars Ryden

01:51

What does lowering the risk of CV death? - Lars Ryden
What are your thoughts on the 35% relative risk reduction?

01:42

What are your thoughts on the 35% relative risk reduction?
Reduce the risk of CV death with Jardiance - 1/3

01:01

Reduce the risk of CV death with Jardiance - 1/3
Long term benefit of Jardiance on life expectancy

01:00

Long term benefit of Jardiance on life expectancy
Load more